Skip to main content

Advertisement

Log in

18FDG-PET/CT Imaging in Breast Cancer Patients with Clinical Stage IIB or Higher

Commentary on “Overuse of Preoperative Staging of Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer” by Marissa K. Srour et al.

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Srour MK, Lee M, Walcott-Sapp S, Luu M, Chung A, Giuliano AE, et al. Overuse of preoperative staging of patients undergoing neoadjuvant chemotherapy for breast cancer. Ann Surg Oncol. 2019;26:3289–94.

    Article  Google Scholar 

  2. Groheux D, Hindié E, Delord M, Giacchetti S, Hamy A-S, de Bazelaire C, et al. Prognostic impact of 18FDG-PET-CT findings in clinical stage III and IIB breast cancer. J Natl Cancer Inst. 2012;104:1879–87.

    Article  Google Scholar 

  3. Segaert I, Mottaghy F, Ceyssens S, De Wever W, Stroobants S, Van Ongeval C, et al. Additional value of PET-CT in staging of clinical stage IIB and III breast cancer. Breast J. 2010;16:617–24.

    Article  Google Scholar 

  4. Ulaner GA, Castillo R, Goldman DA, Wills J, Riedl CC, Pinker-Domenig K, et al. 18F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer. Eur J Nucl Med Mol Imaging. 2016;43:1937–44.

    Article  CAS  Google Scholar 

  5. Ulaner GA, Castillo R, Wills J, Gönen M, Goldman DA. 18F-FDG-PET/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancer. Eur J Nucl Med Mol Imaging. 2017;44:1420–7.

    Article  CAS  Google Scholar 

  6. Ulaner GA. PET/CT for patients with breast cancer: where is the clinical impact? AJR Am J Roentgenol. 2019;213:254–65.

    Article  Google Scholar 

  7. Lebon V, Alberini J-L, Pierga J-Y, Diéras V, Jehanno N, Wartski M. Rate of distant metastases on 18F-FDG PET/CT at initial staging of breast cancer: comparison of women younger and older than 40 years. J Nucl Med. 2017;58:252–7.

    Article  CAS  Google Scholar 

  8. Groheux D, Giacchetti S, Delord M, Hindié E, Vercellino L, Cuvier C, et al. 18F-FDG PET/CT in staging patients with locally advanced or inflammatory breast cancer: comparison to conventional staging. J Nucl Med. 2013;54:5–11.

    Article  Google Scholar 

  9. Salaün P-Y, Abgral R, Malard O, Querellou-Lefranc S, Quere G, Wartski M, et al. Good clinical practice recommendations for the use of PET/CT in oncology. Eur J Nucl Med Mol Imaging. 2020;47(1):28–50. https://doi.org/10.1007/s00259-019-04553-8.

    Article  PubMed  Google Scholar 

  10. Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, et al. Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30:1194–220.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David Groheux MD, PhD.

Ethics declarations

Disclosure

David Groheux and Elif Hindié declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Groheux, D., Hindié, E. 18FDG-PET/CT Imaging in Breast Cancer Patients with Clinical Stage IIB or Higher. Ann Surg Oncol 27, 1708–1709 (2020). https://doi.org/10.1245/s10434-019-08188-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-019-08188-9

Navigation